List of Key Players in the Global Cardiac
Resynchronization Therapy Market:
- Abbott
- BIOTRONIK Asia Pacific Pte. Ltd.
- Boston Scientific Corporation
- MEDICO S.R.L.
- Medtronic
- MicroPort Scientific Corporation
View Full Report Link: https://www.absolutemarketsinsights.com/reports/Global-Cardiac-Resynchronization-Therapy-Market-2021-2029-1047
Key Findings of the Report:
- Cardiac resynchronization therapy pacemaker (CRT-P)
device type is estimated to grow at the fastest rate in the global cardiac
resynchronization therapy market during the forecast period. In the last
ten years, there have been increasing number of patients with cardiac and
heart failures. The demand for CRT-P has risen as CRT-P pacemaker is an
implantable cardiac resynchronization treatment (CRT) pacemaker that
monitors the heart's rhythm, detects anomalies, and corrects them with
electrical impulses. The introduction of leadless pacemaker devices has
been a paradigm breakthrough in pacemaker technology and is proving to be
a huge advantage in cardiac resynchronization therapy.
- Abnormal heart rhythm is anticipated to be the
fastest growing therapeutic indication in the global cardiac
resynchronization therapy market over the future years. A cardiac
resynchronization therapy is usually recommended if the rhythm is
abnormally slow because the heart’s lower chambers (ventricles) are
beating out of sync or enlarged heart or cardiomyopathy. Thus, in order to
resynchronize the heartbeat, cardiac resynchronization therapy (CRT) uses
a special pacemaker called a CRT pacemaker or a biventricular pacemaker.
- Due to the rise in ageing population, there has been
an increased demand for cardiovascular critical care, which is reflected
in trends in the use of critical care in general. Specialty cardiac
centers are forecasted to be the fastest growing segment in the global
cardiac resynchronization therapy market. For instance, Cleveland Clinic offers
CRT-HF Follow-Up Clinic, is a specialized, one-time, multidisciplinary
clinic designed for all patients who received a CRT pacemaker or
defibrillator. During the visit, a team of specialists assess how well the
device has helped the patient and whether there is a way to improve
cardiac drugs or device settings. Thus, with advanced healthcare
assistance, the global cardiac resynchronization therapy market is
boosting globally.
Global Cardiac Resynchronization Therapy Market:
By Device Type
- Cardiac Resynchronization Therapy Defibrillator
(CRT-D)
- Cardiac Resynchronization Therapy Pacemaker (CRT-P)
By Therapeutic Indication
- Heart Failure (Moderate to Severe)
- Abnormal Heart Rhythm
By End Users
- Hospitals & Clinics
- Specialty Cardiac Centers
- Ambulatory Surgical Centers
By Region
- North America (U.S., Canada, Mexico, Rest of North
America)
- Europe (France, The UK, Spain, Germany, Italy,
Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux
Union (Belgium, The Netherlands, Luxembourg) and Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand,
Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia,
Singapore, Rest of Southeast Asia) and Rest of Asia Pacific
- Middle East and Africa (Saudi Arabia, UAE, Egypt,
Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin
America)
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
